NCT02034201View on ClinicalTrials.gov

Clinical Efficacy of Lisdexamfetamine for Methamphetamine Dependence

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

May 19, 2016

Study Completion Date

May 19, 2016

Conditions
Methamphetamine Dependence
Interventions
DRUG

Lisdexamfetamine

DRUG

Placebo

Trial Locations (1)

72205

University of Arkansas for Medical Sciences, Little Rock

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Arkansas

OTHER

NCT02034201 - Clinical Efficacy of Lisdexamfetamine for Methamphetamine Dependence | Biotech Hunter | Biotech Hunter